More than two fifths of investors planning to increase their pharma exposure

27th May 2014

Investors are increasingly interested in pharmaceutical stocks according to a poll from Barclays Stockbrokers. The poll which ran between 14th May and 22 May 2014, asked investors for their current outlook on pharma.

More than two fifths (41 per cent) expect the sector to continue to grow and are planning to invest more in pharmaceutical stocks. A further ten per cent said that positive outlook for the sector means that they are planning to invest in pharmaceutical stocks for the first time.

Seven per cent of respondents said they plan to invest less in pharmaceutical stocks as they think the sector is ripe for a correction and 17 per cent said that they do not plan to invest in pharmaceutical stocks.

More than a quarter (26 per cent) of Barclays Stockbrokers’ clients said they were unsure of their investment plans.

Chris Stevenson, vice president, at Barclays Stockbrokers, said: “While the pharmaceutical sector is dominating media headlines, our clients’ are continuing to see the value in investing in this sector.  We are consistently seeing our investors take interest in those sectors which they believe will deliver returns over the long term.”

Register here for Neil Woodford updates and receive a free research report.

Leave a Reply

Your email address will not be published. Required fields are marked *